What Is Fatty Liver Disease? Understanding NAFLD and MASLD

You've just received lab work showing elevated liver enzymes, and your doctor mentions "fatty liver disease." Your first thought: How did that happen? I'm not a heavy drinker. This is actually one of the most common conversations happening in clinics today — and you're far from alone.

Fatty liver disease is one of the most prevalent chronic liver conditions globally, affecting roughly one in three to four adults worldwide. Despite how common it is, many people don't realize they have it until routine blood tests or imaging reveal the truth. Understanding what it is, why it matters, and what you can do about it is the first step toward taking control of your liver health.

What Is Fatty Liver Disease?

At its core, fatty liver disease is simple: your liver has accumulated too much fat. In a healthy liver, fat makes up less than 5% of the organ's weight. When fat exceeds 5% of liver weight, doctors call it hepatic steatosis — or more commonly, a fatty liver.

Here's the important part: fat in the liver isn't inherently dangerous in small amounts. The problem arises when your metabolic health begins to deteriorate, triggering inflammation and injury. That's when fatty liver becomes a concern.

For decades, doctors divided fatty liver into two categories: NAFLD (nonalcoholic fatty liver disease) and AFLD (alcoholic fatty liver disease). But in 2023, major medical organizations including the American Association for the Study of Liver Diseases (AASLD) realized the terminology needed to change.

Why the Name Changed: NAFLD to MASLD

The term "nonalcoholic" is exclusionary — it defines the condition by what it's not rather than what it is. More importantly, it carried stigma. The word "fatty" felt judgmental, and the emphasis on "nonalcoholic" suggested patients without drinking problems shouldn't have liver disease, which isn't true.

In 2023, over 200 liver experts, public health officials, and patient advocates voted on new terminology. The consensus was clear: metabolic dysfunction is the real culprit.

NAFLD is now MASLD — metabolic dysfunction-associated steatotic liver disease. NASH is now MASH — metabolic dysfunction-associated steatohepatitis.

This change reflects an important scientific truth: fatty liver disease isn't about moral failings or poor choices alone. It's about metabolic dysfunction — your body's struggle to regulate blood sugar, cholesterol, and inflammation.

Who Develops MASLD?

MASLD is driven by metabolic risk factors. You're at higher risk if you have:

• Obesity or overweight (BMI > 25)
• Type 2 diabetes (65% of people with diabetes have MASLD)
• High blood pressure
• Abnormal cholesterol or triglycerides
• Metabolic syndrome (a cluster of these conditions)

Globally, MASLD affects approximately 38% of adults. In some regions, like Asia and South America, prevalence reaches 30–34%. Among people with type 2 diabetes, the rate climbs to 65% — more than one in two.

What's striking is that MASLD doesn't discriminate by weight. While obesity is a major risk factor, lean individuals can develop it too, especially if they have metabolic dysfunction or insulin resistance. Age matters as well; prevalence increases with age, peaking in the 50s and 60s.

Why Should You Care?

Here's the sobering part: MASLD is silent. You typically feel fine. Your liver doesn't send pain signals. But underneath, inflammation and oxidative stress can gradually scar your liver — a process called fibrosis.

The risk is progression:

• Simple steatosis (fat alone) → Steatohepatitis (fat + inflammation) → Fibrosis (scarring) → Cirrhosis (irreversible damage)

This progression doesn't happen overnight. For many people, it takes 10–30 years to move from simple fatty liver to cirrhosis. But the key word is can. Not everyone progresses, and even those who do have a long window to intervene.

The encouraging news: early-stage liver disease is highly reversible. A 10% loss of body weight can decrease or even reverse scarring. Treating diabetes, lowering blood pressure, and improving metabolic health directly improve liver health.

The Numbers That Matter

Because MASLD is silent in its early stages, blood tests and imaging are often how it's found. Here are the key markers your doctor may check:

• ALT (alanine aminotransferase): An enzyme released when liver cells are damaged. Persistently elevated ALT — typically above 33 U/L for men or 25 U/L for women — can signal ongoing liver inflammation.
• AST (aspartate aminotransferase): Another liver enzyme, often paired with ALT. The AST/ALT ratio can hint at disease severity.
• GGT (gamma-glutamyl transferase): Elevated GGT often accompanies fatty liver and metabolic syndrome.
• FIB-4 score: A composite index that uses your age, ALT, AST, and platelet count to estimate fibrosis risk. A FIB-4 below 1.30 is reassuring; above 2.67 warrants further investigation. (We'll cover FIB-4 in detail in an upcoming article.)

None of these numbers alone tells the whole story. They're pieces of a puzzle your hepatologist assembles alongside imaging (ultrasound, FibroScan, MRI-PDFF) and your clinical history.

The Global Burden Is Growing

MASLD is already the leading cause of liver disease in developed countries, and it's rising rapidly worldwide. Projections suggest that by 2040, MASLD will affect more than half of adults globally. This isn't scaremongering — it's a call to action.

The good news is that you're reading this, which means you're already taking the first step: gaining awareness.

What You Can Do About It

MASLD is a metabolic disease, not a liver disease alone. Fixing it means addressing your whole metabolic picture: your weight, blood sugar control, cholesterol, blood pressure, and inflammation. It's not a quick fix, but it's very fixable.

The evidence consistently points to three pillars of MASLD management:

1. Dietary change. The Mediterranean diet is the most studied eating pattern for fatty liver. It emphasizes olive oil, fish, vegetables, whole grains, and moderate amounts of fruit — while limiting fructose, ultra-processed foods, and added sugars.

2. Intermittent fasting. Time-restricted eating protocols like 16:8 have shown meaningful reductions in hepatic fat and ALT levels in multiple clinical trials. Fasting helps by improving insulin sensitivity, mobilizing liver fat stores, and promoting autophagy — a cellular cleanup process. (See our fasting and fatty liver guide for the evidence.)

3. Regular movement. Both aerobic exercise and resistance training reduce liver fat independently of weight loss. Even 150 minutes of moderate activity per week — brisk walking counts — makes a measurable difference (Hashida et al., 2017).

Your liver is one of the most resilient organs in your body. It can regenerate and repair itself if given the chance. The question isn't whether change is possible — it's whether you're ready to make it.

How LivaFast Helps

If you've been diagnosed with MASLD or are concerned about your liver health, tracking your progress is essential. LivaFast's Liver Progress Score (LPS) is designed exactly for this purpose. Your LPS combines your key health metrics — liver enzymes, body metrics, metabolic markers, and fasting patterns — into a single score that reflects your liver's health trajectory.

Instead of obsessing over individual lab values, you can watch your LPS trend upward as you make better choices. The app also lets you log and track your lab values (ALT, AST, GGT) over time, so you can see the concrete impact of diet, exercise, and weight loss on your actual numbers.

Beyond tracking, LiVA, LivaFast's AI health coach, offers personalized insights about how your daily habits affect your liver health. And the 12-Week Journey program guides you through evidence-based lifestyle changes specifically designed to improve metabolic health and reduce liver fat.

Key Takeaways

• Fatty liver disease (now called MASLD) affects 1 in 3 adults globally and is driven by metabolic dysfunction, not moral failings.
• MASLD is usually silent but can progress to cirrhosis over decades — or it can improve with early intervention.
• A 10% weight loss, better blood sugar control, and metabolic improvements can reverse fatty liver.
• Most people feel fine with MASLD, which is why tracking and awareness are critical.
• You have more power over your liver health than you might think.

Sources

1. The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes — Clinical Gastroenterology and Hepatology
2. Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021 — PMC/NIH
3. The burden of NAFLD-related chronic liver disease and cirrhosis from 1990 to 2021 with projections to 2036 — PMC/NIH
4. Examining the Nomenclature Change From NAFLD and NASH to MASLD and MASH — PMC/NIH
5. New MASLD Nomenclature — American Association for the Study of Liver Diseases

---

This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your diet or treatment plan.